Geburtshilfe Frauenheilkd 2017; 77(05): 482-486
DOI: 10.1055/s-0043-107784
GebFra Science
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Rates and Routes of Hysterectomy for Benign Indications in Austria 2002 – 2014

Hysterektomieraten und Zugangswege in Österreich 2002 – 2014
Katharina Maria Edler
1   Department of Obstetrics & Gynecology, Medical University of Graz, Graz, Austria
2   Department of Obstetrics & Gynecology, Krankenhaus Dornbirn, Dornbirn, Austria
,
Karl Tamussino
1   Department of Obstetrics & Gynecology, Medical University of Graz, Graz, Austria
,
Gerhard Fülöp
3   Gesundheit Österreich GmbH, Vienna, Austria
,
Evi Reinstadler
2   Department of Obstetrics & Gynecology, Krankenhaus Dornbirn, Dornbirn, Austria
,
Walter Neunteufel
2   Department of Obstetrics & Gynecology, Krankenhaus Dornbirn, Dornbirn, Austria
,
Philipp Reif
1   Department of Obstetrics & Gynecology, Medical University of Graz, Graz, Austria
,
Rene Laky
1   Department of Obstetrics & Gynecology, Medical University of Graz, Graz, Austria
,
Thomas Aigmüller
1   Department of Obstetrics & Gynecology, Medical University of Graz, Graz, Austria
› Author Affiliations
Further Information

Publication History

received 08 February 2017
revised 27 March 2017

accepted 30 March 2017

Publication Date:
24 May 2017 (online)

Abstract

Introduction Rates and routes of hysterectomy have implications for quality, costs and training. This study analyzed rates of benign hysterectomy and surgical approaches for benign hysterectomy in Austria from 2002 to 2014.

Material and Methods This was a population-based retrospective observational study of coding data from all acute care hospitals (public and private) in Austria. Main outcome measures were numbers of women undergoing hysterectomy for benign indications in Austria per year and the route of hysterectomy for benign indications.

Results The number of benign hysterectomies performed per year declined from 10 675 in 2002 to 7747 in 2014, a decline of 27%. The use of vaginal hysterectomy was stable (53% and 47%, respectively). Use of laparoscopic techniques increased (5% in 2002, 32% in 2014) whereas use of abdominal hysterectomy decreased (41% and 20%, respectively).

Conclusions Numbers of benign hysterectomies performed per year in Austria declined substantially between 2002 and 2014. Use of vaginal hysterectomy was stable at about 50%, whereas increased use of laparoscopic techniques was associated with lower rates of open hysterectomy.

Zusammenfassung

Einleitung Die Anzahl durchgeführter Hysterektomien und der gewählte operative Zugangsweg haben Implikationen für Qualität, Kosten und ärztliche Ausbildung. In dieser Studie wurden die Anzahl der in Österreich zwischen 2002 und 2014 durchgeführten benignen Hysterektomien und der gewählte operative Zugangsweg untersucht.

Material und Methoden Es handelt sich hier um eine retrospektive bevölkerungsbezogene Beobachtungsstudie basierend auf codierten Daten aus allen (öffentlichen und privaten) Akutkrankenhäusern in Österreich. Die wichtigsten Ergebnisse waren die jährliche Anzahl der Frauen in Österreich, die sich einer Hysterektomie für benigne Grunderkrankung unterzogen, sowie der gewählte operative Zugangsweg.

Ergebnisse Die Anzahl der jährlich durchgeführten Hysterektomien für benigne Erkrankungen ging von 10 675 im Jahre 2002 zurück auf 7747 im Jahre 2014, was einem Rückgang von 27% entspricht. Der Anteil vaginaler Hysterektomien blieb relativ stabil (53% resp. 47%). Laparoskopische Methoden wurden zunehmend eingesetzt (5% im Jahre 2002, 32% im Jahre 2014), während der Anteil abdominaler Hysterektomien abgenommen hat (41% resp. 20%).

Schlussfolgerungen Die Anzahl der jährlich in Österreich für benigne Grunderkrankungen durchgeführten Hysterektomien ist zwischen 2002 und 2014 erheblich zurückgegangen. Der Anteil vaginaler Hysterektomien blieb stabil mit ca. 50%, wohingegen der verstärkte Einsatz laparoskopischer Verfahren mit niedrigeren Raten von abdominalen Hysterektomien einherging.

 
  • References

  • 1 Falcone T, Walters MD. Hysterectomy for benign disease. Obstet Gynecol 2008; 111: 753-767
  • 2 Gimbel H, Settnes A, Tabor A. Hysterectomy on benign indication in Denmark 1988–1998. A register based trend analysis. Acta Obstet Gynecol Scand 2001; 80: 267-272
  • 3 Spilsbury K, Semmens J, Hammond I. et al. Persistent high rates of hysterectomy in Western Australia: a population-based study of 83000 procedures over 23 years. BJOG 2006; 113: 804-809
  • 4 Schweizer Gesundheitsobservatorium. Hospitalisationsrate in somatischen Akutspitälern wegen Gebärmutterentfernung (Hysterektomie) pro 1000 Einwohnerinnen und Kaiserschnitt pro 1000 Geburten. Obsan November 2007 (Indikator 6.4.13).
  • 5 Whiteman MK, Hillis SD, Jamieson DJ. et al. Inpatient hysterectomy surveillance in the United States, 2000–2004. Am J Obstet Gynecol 2008; 198: 34.e1-34.e7
  • 6 Lundholm C, Forsgren C, Johansson AL. et al. Hysterectomy on benign indications in Sweden 1987–2003: a nationwide trend analysis. Acta Obstet Gynecol Scand 2009; 88: 52-58
  • 7 Stang A, Merrill RM, Kuss O. Hysterectomy in Germany: a DRG-based nationwide analysis, 2005–2006. Dtsch Arztebl Int 2011; 108: 508-514
  • 8 Cromwell D, Mahmood T, Templeton A. et al. Surgery for menorrhagia within English regions: variation in rates of endometrial ablation and hysterectomy. BJOG 2009; 116: 1373-1379
  • 9 Hanstede MM, Burger MJ, Timmermans A. et al. Regional and temporal variation in hysterectomy rates and surgical routes for benign disease in the Netherlands. Acta Obstet Gynecol Scand 2012; 91: 220-225
  • 10 Doll KM, Dusetzina SB, Robinson W. Trends in inpatient and outpatient hysterectomy and oophorectomy rates among commercially insured women in the United States, 2000–2014. JAMA Surg 2016; 151: 876-877
  • 11 Wright JD, Herzog TJ, Tsui J. et al. Nationwide trends in the performance of inpatient hysterectomy in the United States. Obstet Gynecol 2013; 122: 233-241
  • 12 Gante I, Medeiros-Borges C, Águas F. Hysterectomies in Portugal (2000–2014): what has changed?. Eur J Obstet Gynecol Repod Biol 2017; 208: 97-102
  • 13 Aarts JWM, Nieboer TE, Johnson N. et al. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev 2015; (08) CD003677
  • 14 Domenighetti G, Casabianca A. Rate of hysterectomy is lower among female doctors and lawyersʼ wives. BMJ 1997; 314: 1417
  • 15 Domenighetti G, Luraschi P, Casabianca A. et al. Effect of information campaign by the mass media on hysterectomy rates. Lancet 1988; 2: 1470-1473
  • 16 Brölmann HA, Vervest HA, Heineman MJ. Declining trend in major gynaecological surgery in The Netherlands during 1991–1998. Is there an impact on surgical skills and innovative ability?. BJOG 2001; 108: 743-748
  • 17 Hall RE, Cohen MM. Variations in hysterectomy rates in Ontario: does the indication matter?. CMAJ 1994; 151: 1713-1719
  • 18 Jacobson GF, Shaber RE, Armstrong MA. et al. Changes in rates of hysterectomy and uterus-conserving procedures for treatment of uterine leiomyoma. Am J Obstet Gynecol 2007; 196: 601.e1-601.e5
  • 19 David-Montefiore E, Rouzier R, Chapron C. et al. Surgical routes and complications of hysterectomy for benign disorders: a prospective observational study in French university hospitals. Hum Reprod 2007; 22: 260-265
  • 20 Brummer TH, Jalkanen J, Fraser J. et al. FINHYST, a prospective study of 5279 hysterectomies: complications and their risk factors. Hum Reprod 2011; 26: 1741-1751
  • 21 Reid PC, Mukri F. Trends in number of hysterectomies performed in England for menorrhagia: examination of health episode statistics, 1989 to 2002–3. BMJ 2005; 330: 938-939
  • 22 Topsoee MF, Ibfelt EH, Settnes A. The Danish hysterectomy and hysteroscopy database. Clin Epidemiol 2016; 8: 515-520
  • 23 Wright JD, Ananth CV, Lewin SN. et al. Robotically assisted vs. laparoscopic hysterectomy among women with benign gynecologic disease. JAMA 2013; 309: 689-698
  • 24 Harris JA, Swenson CW, Uppal S. et al. Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation. Am J Obstet Gynecol 2016; 214: 98.e1-98.e13
  • 25 Saadat S, Arden D. How has the U.S. Food and Drug Administration morcellation warning affected rates of minimally invasive hysterectomy in a large multi-center managed care setting? [Abstract]. Am J Obstet Gynecol 2017; 216 (Suppl.) S572
  • 26 ACOG Committee Opinion No. 444: Choosing the route of hysterectomy for benign disease. Obstet Gynecol 2009; 114: 1156-1158
  • 27 Neis KJ, Zubke W, Römer T. et al. Indications and route of hysterectomy for benign diseases – Guidelines of the DGGG, OEGGG and SGGG. Geburtsh Frauenheilk 2016; 76: 350-364
  • 28 Deffieux X, Rochambeau Bd. Chene G. et al. Hysterectomy for benign disease: clinical practice guidelines from the French College of Obstetrics and Gynecology. Eur J Obstet Gynecol Reprod Biol 2016; 202: 83-91